Pregnancy and lupus nephritis

Scandinavian Journal of Urology and Nephrology

Volumn 35, Issue 4, 2001, Pages 319-327

  Julkunen, H ^a  

^a PEIJAS HOSPITAL   (Finland)

Author keywords

Contraception; Drug treatment; Fertility; Lupus nephritis; Pregnancy

Indexed keywords

ALKYLATING AGENT; ESTROGEN; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY;

ARTICLE; CREATININE BLOOD LEVEL; FAMILY PLANNING; FEMALE; FEMALE FERTILITY; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; PREECLAMPSIA; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; TREATMENT CONTRAINDICATION;

CONTRACEPTIVES, ORAL, HORMONAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FETAL DEATH; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 0034807128     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655901750425927     Document Type: Article

References (87)

1. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1000 patients
2. Contraceptive practice in women with systemic lupus erythematosus
3. Oral contraceptives and systemic lupus erythematosus
4. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy
5. Lupus nephropathy and pregnancy
6. Lupus nephritis and pregnancy
7. Renal lupus in pregnancy
8. Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus
9. The kidney and hypertension in pregnancy
10. Reproductive function in patients with renal insufficiency
11. Clinical aspects of renal transplantation
12. Risk of sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy
13. Immunosuppressive therapy in lupus nephritis
14. Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide
15. Effects of anti-inflammatory and immunosuppressive drugs on pregnancy and fertility
16. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus
17. Oral contraceptives in systemic lupus erythematosus: Side-effects and influence on the activity of SLE
18. Can women with systemic lupus erythematosus safely use exogenous estrogens?
19. Lupus anticoagulant associated with renal thrombotic microangiopathy and renal failure
20. Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman on oral contraceptives
21. Complications of oral contraceptives and antiphospholipid antibodies
22. Contraception with progestagens in systemic lupus erythematosus
23. Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy
24. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach
25. Lupus and pregnancy studies
26. Outcome of pregnancy in patients with systemic lupus erythematosus: A prospective study
27. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience
28. Increased rate of lupus flare during pregnancy and the puerperium
29. Pregnancy in SLE
30. Systemic lupus erythematosus VI: Analysis of the interrelationship between pregnancy
31. Systemic lupus erythematosus and pregnancy: A prospective study
32. Systemic lupus erythematosus flares during pregnancy
33. The outcome of pregnancy in women with lupus nephritis
34. Pregnancy in lupus nephropathy
35. Hopkins Lupus Pregnancy Center: 1987 to 1996
36. Pregnancy in patients with renal disease. A study of 44 cases
37. Pregnancy and renal disease
38. Pregnancy and its outcome in systemic lupus erythematosus
39. Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies: A case report and review of the literature
40. A new postpartum syndrome associated with antiphospholipid antibodies
41. Hazards of lupus pregnancy
42. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy
43. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and preeclampsia
44. Systemic lupus erythematosus and pregnancy
45. Evaluation of lupus nephritis during pregnancy by renal biopsy
46. The association of antiphospholipid antibodies with severe preeclampsia
47. An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy: A report of two cases
48. Fetal outcome in lupus pregnancy. A retrospective case-control study of 242 pregnancies in 112 patients
49. Obstetric outcome in systemic lupus erythematosus
50. Systemic lupus erythematosus in pregnancy
51. Clinical predictors for fetal outcome in systemic lupus erthematosus
52. Antiphospholipid syndrome in pregnancy
53. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience
54. Histopathological findings in placentae from patients with intrauterine fetal death and antiphospholipid antibodies
55. What really happens to fecundity in autoimmune diseases?
56. Fetal outcome in lupus pregnancy: The prognostic significance of untreated and treated lupus anticoagulant
57. Diagnosis of the antiphospholipid syndrome: A proposal for use of laboratory tests
58. Anti-beta2-glycoprotein 1 antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome
59. Isolated congenital heart block: Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and SS-B/La
60. Neonatal lupus syndromes
61. Successful birth in a hemodialysis patient with SLE
62. Reactivation of systemic lupus erythematosus by pregnancy in a hemodialysis patient
63. Renal transplantation in systemic lupus erythematosus. A case control study of 45 patients
64. Pregnancy and dialysis
65. Perinatal and infant outcome of pregnant patients undergoing chronic hemodialysis
66. Pregnancy in women receiving renal dialysis or transplantation in Japan: A nationwide survey of pregnancies on renal replacement therapy in Japan
67. Obstetrtic management of the high-risk pregnancy
68. Safety of nonsteroidal anti-inflammatory drugs in pregnant patients with rheumatic diseases
69. Successful child bearing during intravenous cyclophosphamide therapy in a patient with systemic lupus erythematosus
70. Canadian Hydroxychloquine Study Group: A randomized study of the effect of withdrawing hydroxychloquine sulfate in systemic lupus erythematosus
71. Hydroxychloroquine and lupus pregnancy: Review of a series of 36 cases
72. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus
73. Pregnancy outcome following first trimester exposure to chloroquine
74. International society of hypertension guidelines for the management of hypertension
75. Treatment of the antiphospholipid syndrome in pregnancy
76. Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies: A pilot study of treatment with intravenous immunoglobulin
77. Fetal survival after prednisone suppression of maternal lupus anticoagulant
78. Prevention of anticardiolipin-related pregnancy losses with prednisone and aspirin
79. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomised trial comparing prednisone to low dose heparin treatment
80. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients
81. A study of sixty pregnancies in patients with the antiphospholipid syndrome
82. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies
83. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
84. Antiphosholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to treatment with aspirin alone
85. Prevention of thromboembolism in pregnancy
86. Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: A review